Department of Oral and Maxillofacial Radiology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.
Department of Oral and Maxillofacial Radiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553, Japan.
Oral Radiol. 2024 Apr;40(2):158-164. doi: 10.1007/s11282-023-00716-4. Epub 2023 Oct 13.
This study aimed to investigate the incidence of osteonecrosis of the jawbones (ORN) after tooth extraction in patients undergoing low-dose rate brachytherapy (LDR-BT) and assess its safety.
This study retrospectively analyzed 145 patients with tongue cancer treated at Hiroshima University Hospital from 2007 to 2021 with LDR-BT using 192Ir or 198Au alone, LDR-BT and external beam radiotherapy (EBRT) with or without chemotherapy, and LDR-BT with chemotherapy. Patients' mandible and maxilla were protected with spacers. Forty-seven patients underwent tooth extraction, and the incidence, site, and relationship of ORN with tooth extraction were recorded. A subgroup of 26 patients received additional EBRT to the neck after dissection for late cervical lymph node metastases.
Of 145 patients, six (4.1%) developed ORN on the same side of the mandible as LDR-BT, and EBRT was performed before and/or after LDR-BT on the sites where ORNs developed. Five of 47 (10.6%) patients who underwent tooth extraction after LDR-BT developed ORN. ORN incidence was 1.8% (2/109) in the LDR-BT and/or chemotherapy group and 11.1% (4/36) in the combination LDR-BT and EBRT and/or chemotherapy group for primary tongue cancer. Different irradiation methods (LDR-BT and/or chemotherapy and combination LDR-BT and EBRT and/or chemotherapy) and the presence or absence of tooth extraction showed significant differences (p = 0.0335 and p = 0.0139, respectively) with or without ORN.
Mandibular tooth extraction should be avoided on the side of LDR-BT in combined EBRT cases. However, tooth extraction is feasible using a spacer in LDR-BT and/or chemotherapy.
本研究旨在调查接受低剂量率近距离放射治疗(LDR-BT)的患者拔牙后颌骨骨坏死(ORN)的发生率,并评估其安全性。
本研究回顾性分析了 2007 年至 2021 年广岛大学医院收治的 145 例舌癌患者,这些患者单独接受 192Ir 或 198Au 进行 LDR-BT、LDR-BT 联合外照射放疗(EBRT)加或不加化疗,以及 LDR-BT 联合化疗。患者的下颌骨和上颌骨均用间隔物保护。47 例患者接受了拔牙,记录了 ORN 的发生率、部位以及与拔牙的关系。26 例患者在接受颈清扫术治疗晚期颈部淋巴结转移后,接受了额外的颈部 EBRT。
145 例患者中,6 例(4.1%)在接受 LDR-BT 的同侧下颌骨发生 ORN,在发生 ORN 的部位行 LDR-BT 前和/或后行 EBRT。47 例接受 LDR-BT 后拔牙的患者中有 5 例(10.6%)发生 ORN。在原发性舌癌患者中,LDR-BT 和/或化疗组 ORN 发生率为 1.8%(2/109),LDR-BT 联合 EBRT 和/或化疗组为 11.1%(4/36)。有无 ORN 时,不同的照射方法(LDR-BT 和/或化疗与 LDR-BT 联合 EBRT 和/或化疗)和拔牙与否差异有统计学意义(p=0.0335 和 p=0.0139)。
在联合 EBRT 的情况下,应避免在 LDR-BT 侧进行下颌牙拔除。然而,在 LDR-BT 和/或化疗中使用间隔物进行拔牙是可行的。